Where does National Jewish Health rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), National Jewish Health ranks #5,964 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does National Jewish Health hold?

National Jewish Health holds 57 US utility patents granted between 2015 and 2025, spanning 29 technology areas.

What is National Jewish Health's Innovation Score?

National Jewish Health has an Innovation Score of 46.4 out of 100 (top 21% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does National Jewish Health focus on?

National Jewish Health's top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 33 patents, ranking #585 of 6,058 assignees active in that subclass. Grants appear in 29 CPC subclasses total.

Is National Jewish Health's patent grant rate increasing or decreasing?

National Jewish Health's recent grant velocity is +24% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for National Jewish Health's patents?

National Jewish Health's patents average 10.5 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the National Jewish Health patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

National Jewish Health

USPTO PatentsView assignee record - 57 granted patents across 29 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, National ranks #5,964 of 49,997 tracked US assignees by granted-patent volume, with 57 patents across 29 technology areas.

#5,964
of 49,997 US assignees by volume: Top 21%
by Innovation Score (46.4/100): 10.5
avg claims per patent: +24%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R5964 · US Corporation #5,964 · 57 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-PAR · TYPE-USCORP · VEL-UP · BOOK-FULL

GRANTS-SMALL 57 grants
UPPER-Q #5,964/49,997
PHOTO-FINISH MGI Tech
CPC-FOCUS A61P · 29 areas
INNOV-PAR 46.4/100
CLAIMS-PAR 10.5 claims/avg
TYPE-USCORP US Corporation
VEL-UP +24% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: MGI Tech Co., Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How National’s 46.4 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 14.0 pts (30%) Velocity 7.1 pts (15%) Breadth 19.0 pts (41%) Claim depth 6.3 pts (14%)

Qualcomm Incorporated · highest

85
Boston Medical Center · near

46
Hanwha Chemical · near

46
National Jewish Health · this assignee

46
Nippon Chemi-Con · near

46
Red Hat Israel · near

46
3D Lighting… · lowest

7

What this shows National's Innovation Score is 46.4/100 (top 21% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for National?

Each dot is one of National’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). National’s own 10.5 claims/patent is at or below the 15.7 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

National vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where National's grants concentrate

National Jewish Health is a focused PatentsView assignee: 29 CPC subclasses with 57.9% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2024 (10 grants) versus a trough of 2 in 2023. By volume, National sits between MGI Tech Co., Ltd. and Phytogen Seed Company, LLC.

National's three-year grant acceleration

National Jewish Health shows 18 grants in 2022–2024 against only 17 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

MGI Tech

57
Mitsui Chemicals…

57
Misonix

57
North University…

57
North Atlantic Im…

57
Omnitracs

57
Ovonyx Memory Tec…

57
Phytogen Seed

57
National Jewish H… ◀

57

What this shows National holds 57 patents at rank #5,963, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near National

By rank, the assignees closest to #5,963 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in National's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for National, neither rank-band nor same-CPC leaders (those blocks stay above). In A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…), National ranks #585 of 6,058 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (46 here).

Hanwha Chemical Corporation 46 Boston Medical Center Corporation 46 Nippon Chemi-Con Corporation 46 Red Hat Israel Ltd. 46

Similar claim depth

Nearest assignees by average claims per patent (10.5 here).

Ubicquia, Inc. 10.5 avg ABB Oy 10.5 avg Korea Institute OF Industrial Technology 10.5 avg Eagle Industry Co., Ltd. 10.5 avg

National's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

46 Top 21% higher than 79% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

National Jewish Health patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	3	5.3%
2016	6	10.5%
2017	4	7.0%
2018	8	14.0%
2019	4	7.0%
2020	9	15.8%
2021	4	7.0%
2022	6	10.5%
2023	2	3.5%
2024	10	17.5%
2025partial year	1	1.8%

Which technologies does National Jewish Health patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 33

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 28

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 19

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 16

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 16

C07K - Peptides 9

G16B - Bioinformatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR Genetic OR Protein-related Data Processing IN Computational Molecular Biology 8

A61B - DIAGNOSIS; SURGERY; Identification 8

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 7

C12Y - Enzymes 6

G06N - Computing Arrangements Based ON Specific Computational Models 4

G06T - Image Data Processing OR Generation, IN General 4

C07D - Heterocyclic Compounds 3

G16C - Computational CHEMISTRY; CHEMOINFORMATICS; Computational Materials Science 3

A01N - Preservation OF Bodies OF Humans OR Animals OR Plants OR Parts Thereof ; Biocides, e.g. AS Disinfectants, AS Pesticides OR AS Herbicides ; Pest Repellants OR ATTRACTANTS; Plant Growth Regulators 3

Top 15 of 29 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

National Jewish Health's patent record in context - here's where to go next.

National Jewish Health's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 57.9% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #5,964 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare National Jewish Health against MGI Tech Co., Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 46.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.